Founding and Legal Mandate
The Nigeria Centre for Disease Control and Prevention (NCDC) began operating in 2011, established administratively within the Federal Ministry of Health in response to recurring public health emergencies and the need for stronger national epidemic preparedness. Its core mandate — prevention, detection, and control of communicable diseases through surveillance, laboratory diagnostics, applied epidemiology training, and outbreak response — was formalised seven years later when the National Assembly passed, and the President signed, the Nigerian Centre for Disease Control and Prevention (Establishment) Act, 2018, giving the agency full statutory footing to "promote, coordinate and facilitate the prevention, detection and control of communicable diseases in Nigeria and other events of public health importance" S1S2
Governance Structure
The 2018 Act built a multi-tiered governance framework around the agency: a Governing Board oversees the Centre, with fixed tenure and remuneration rules for its members; a Director General handles day-to-day operational management, supported by departmental staff; and a National Advisory Council provides a separate, wider consultative function. The Act also sets out financial-management provisions covering fund sourcing, expenditure oversight, audit, and annual reporting to government, and it charges the Centre with applied epidemiology training that feeds into the broader public-health workforce pipeline described at nigeria education system S2
The 2014 Ebola Response
NCDC's institutional capacity was tested early. When an infected traveller from Liberia arrived in Lagos on 20 July 2014 and was confirmed with Ebola virus disease, Nigerian health authorities — drawing on NCDC's nascent surveillance system and recent experience managing polio eradication and a 2010 lead-poisoning emergency — rapidly stood up a National Ebola Emergency Operations Centre. Despite Lagos's status as Africa's largest city, with roughly 21 million residents, contact tracing and case management contained the outbreak; the World Health Organization officially declared Nigeria free of Ebola on 20 October 2014, after 42 days without a new confirmed case, calling the outcome a demonstration that "Ebola can be contained" S3
COVID-19 Response
Nigeria's first confirmed COVID-19 case was announced on 27 February 2020: an Italian citizen working in Nigeria who had flown from Milan to Lagos on 25 February 2020 and was confirmed positive by the Virology Laboratory of Lagos University Teaching Hospital, part of NCDC's laboratory network. NCDC activated its national Emergency Operations Centre the same day, coordinated case management with Lagos State health authorities, and began contact tracing of everyone the patient had encountered since arrival, alongside public guidance on hand hygiene, physical distancing, and a toll-free information line — a response that handled what several outlets reported at the time as the first officially confirmed COVID-19 case in sub-Saharan Africa S4
Lassa Fever and Cholera: Recurring Epidemics
Beyond single high-profile outbreaks, NCDC's routine work is dominated by recurring seasonal epidemics of Lassa fever and cholera, both endemic in parts of Nigeria. In 2025, NCDC and WHO situation reports recorded 1,738 combined deaths nationally from cholera, Lassa fever, measles, and diphtheria. Lassa fever alone accounted for 201 deaths from 1,097 confirmed cases (a case-fatality rate of 18.3%) across 21 states and 103 local government areas by mid-December 2025, while cholera caused 500 deaths from 22,102 cases (a 2.3% case-fatality rate) over the same year. NCDC attributed persistent transmission to delayed laboratory confirmation, gaps in infection-prevention practice, limited public communication materials, and vaccine shortages, and it responded by deploying multi-partner rapid-response teams to affected states S5
The 2017 Monkeypox Re-emergence
NCDC's outbreak-response record also includes a disease whose Nigerian resurgence later gained global significance. On 22 September 2017, Bayelsa State reported Nigeria's first suspected human monkeypox case in 39 years; NCDC activated an emergency operations centre on 9 October 2017, developed interim national guidelines, built laboratory diagnostic capacity for human and animal specimens, trained staff in molecular diagnostics, and ran joint human-animal field investigations alongside targeted risk communication. By 25 February 2018, investigators had recorded 228 suspected cases — 89 confirmed and 3 probable — across 24 of Nigeria's 36 states and the Federal Capital Territory, with 6 deaths among confirmed cases (a 6.7% case-fatality rate), according to a peer-reviewed field report co-authored by NCDC and the US CDC S7
Digital Surveillance: SORMAS
Nigeria's experience with Ebola in 2014 also drove a lasting change in how NCDC tracks disease. Beginning in 2015 and scaled up nationally from 2017, Nigeria adopted the Surveillance Outbreak Response Management and Analysis System (SORMAS), a digital case-management and surveillance platform, extending it eventually to all 774 Local Government Areas and all 37 states plus the Federal Capital Territory. SORMAS now forms the backbone of NCDC's real-time outbreak detection, supporting surveillance and response for Lassa fever, meningitis, monkeypox, cholera, and, from 2020, COVID-19 through a dedicated module built onto the existing platform S6
Role in the Wider System
NCDC operates as the specialised disease-surveillance and outbreak-response arm within Nigeria's broader three-tier healthcare structure, described at nigeria healthcare system, and its surveillance systems underpin both the polio eradication effort at nigeria polio eradication and the country's response to future emerging pathogens S1